A detailed history of First Command Advisory Services, Inc. transactions in Argenx Se stock. As of the latest transaction made, First Command Advisory Services, Inc. holds 6 shares of ARGX stock, worth $3,870. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Holding current value
$3,870
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 02, 2025

BUY
$571.0 - $671.75 $3,426 - $4,030
6 New
6 $3,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $35.7B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track First Command Advisory Services, Inc. Portfolio

Follow First Command Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Command Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Command Advisory Services, Inc. with notifications on news.